Benefits

Consistency. Monoclonal antibodies yield reproducible results for consistent patient tracking
Resource savings. The right patients receive the right treatment at the right time
Fast results. Minimal steps for preparation and optimal performance
Productivity. Extensive usability testing for convenience and ease of use
A strong partnership. suPARnostic® specialists collaborate with clinicians and labs to design implementation trials, clinical decision trees and provide technical support

Triaging and Monitoring – Supports Clinician Decision Making
Predicting Patient Survival – suPARnostic® beats all currently used clinical scores and markers
suPARnostic® is a true prognostic marker (no diagnostic value)
suPARnostic® provides critical information that was not evident from PCT
suPARnostic® provides more reliable information than CRP due to stable kinetic characteristics

suPARnostic